Peptinovo Biopharma
PrivateLast Round
Series A
Jan 20, 2026
Est. Valuation
$36.6M
Total Funding Raised
$18.56M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Peptinovo Biopharma is a biotechnology company that develops targeted nanomedicines using its proprietary PALM™ drug-delivery platform to enhance the efficacy of chemotherapy while reducing side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptinovo Biopharma Comparables
Compare Peptinovo Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoNano Medicine | 87% | |
| Cello Therapeutics | 84% | |
| SN BioScience | 83% |
Peptinovo Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 20, 2026 | ||||
| Series A | Dec 16, 2024 | ||||
| SAFE | Jun 21, 2021 |
Peptinovo Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cantilever Opportunity Fund, LP | Series A, VC Round |
| Biosciences Research & Commercialization Center | SAFE |
| ID Ventures | SAFE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 427% MoM, from 259 to 1.4K.
- Jan 20, 2026
$18M round led by Andreessen Horowitz.
Peptinovo Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Peptinovo Biopharma's valuation, stock price, and market status.
Is Peptinovo Biopharma a public or private company?
Peptinovo Biopharma is a private company.
What is the current stock price of Peptinovo Biopharma?
Peptinovo Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is Peptinovo Biopharma worth (valuation)?
Peptinovo Biopharma's valuation is estimated at $36.6M based on funding round data.
Can I buy Peptinovo Biopharma stock?
Peptinovo Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Peptinovo Biopharma's last funding round?
Peptinovo Biopharma's most recent funding round was Series A on January 20, 2026.
Who are the main investors in Peptinovo Biopharma?
Key investors in Peptinovo Biopharma include Cantilever Opportunity Fund, LP.
Will Peptinovo Biopharma IPO soon?
No public IPO plans have been announced for Peptinovo Biopharma.
How can I track Peptinovo Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Peptinovo Biopharma's secondary market activity and sign up for updates.